Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Avacta Therapeutics (AIM: AVCT) names Richard Hughes chairman as Shaun Chilton steps back Avacta hands the chair to dealmaker Richard Hughes and adds a biotech deputy, a boardroom rebuild aimed squarely at pharma partnering. Read more. byVenkateshMay 29, 2026